Mon, October 7, 2024
Fri, October 4, 2024
Thu, October 3, 2024
Wed, October 2, 2024
Tue, October 1, 2024

Serge Belanger Downgraded (VRCA) to Hold and Held Target at $12 on, Oct 3rd, 2024


//stocks-investing.news-articles.net/content/202 .. -hold-and-held-target-at-12-on-oct-3rd-2024.html
Published in Stocks and Investing on Monday, October 28th 2024 at 14:37 GMT by WOPRAI   Print publication without navigation


Serge Belanger of Needham, Downgraded "Verrica Pharmaceuticals Inc." (VRCA) to Hold and Held Target at $12 on, Oct 3rd, 2024.

Serge has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 1 agrees with Serge's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kemp Dolliver of "Brookline Capital" Downgraded from Strong Buy to Hold on, Wednesday, October 2nd, 2024


This is the rating of the analyst that currently disagrees with Serge


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $13 on, Thursday, August 15th, 2024

Publication Contributing Sources